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background: Ukraine has the highest antenatal HIV prevalence in Europe. The national prevention of mother-to-child transmission
(MTCT) programme has reduced the MTCT rate, but less attention has been given to the prevention of unintended pregnancy among
HIV-positive women. Our objectives were to describe the reproductive health, condom use and family planning (FP) practices of HIV-positive
childbearing Ukrainian women and to identify factors associated with different methods of post-natal contraception.
methods: HIV-infected childbearing women, diagnosed before or during pregnancy, were enrolled prospectively in a post-natal cohort
study in four regional HIV/AIDS centres in Ukraine from December 2007. Logistic regression models were used to identify factors associated
with post-natal FP practices.
results: Data were available for 371 women enrolled by March 2009; 82% (n ¼ 303) were married or cohabiting, 27% (97 of 363)
reported a current HIV-negative sexual partner and 69% were diagnosed with HIV during their most recent pregnancy. Overall, 21% (75
of 349) of women were not using contraception post-natally (of whom 80% reported no current sexual activity), 50% (174 of 349) used
condoms, 20% (74 of 349) relied solely/partially on coitus interruptus and 4% used hormonal methods or intrauterine device. Among
married/cohabiting women, consistent use of condoms in the previous pregnancy [AOR 1.96 (95%CI 1.06–3.62)], having an HIV-positive
partner [AOR 0.42 (0.20–0.87)], current sexual activity [AOR 4.53 (1.19–17.3)] and study site were signiﬁcantly associated with post-natal
condom use; 16% of those with HIV-negative partners did not use condoms. Risk factors for non-use of FP were lack of affordability [AOR
6.34 (1.73–23.2)] and inconsistent use of condoms in the previous pregnancy [AOR 7.25 (1.41–37.2)].
conclusions: More than 40% of HIV-positive women in this population are at risk of unintended pregnancy and the one in six women
in HIV-discordant couples not using barrier methods risk transmitting HIV to their partners. Our study results are limited by the observa-
tional nature of the data and the potential for both measured and unmeasured confounding.
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Introduction
The HIV epidemic in Ukraine is the fastest growing in Europe, with
1.63% of the population estimated to be HIV positive (UNAIDS,
2008; Kruglov et al., 2008). An increasing proportion of adults with
HIV-infection are female, estimated at 45% in 2007 (Kruglov et al.,
2008), the vast majority of whom will be of childbearing age. Recent
data indicate that Ukraine also has the highest prevalence of HIV-
positive pregnant women in Europe, at 0.52% (UNAIDS, 2008).
Although the HIV epidemic in Ukraine has been driven by injecting
drug use (IDU), most pregnant HIV-infected women do not have a
IDU history themselves, although many (up to a third) have sexual
partners who have injected drugs (Malyuta et al., 2006; European Col-
laborative Study, 2006).
Women of childbearing age, with and without HIV infection, are at
the centre of the UN Strategic Approach to the Prevention of
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Team on Prevention of HIV infection in pregnant women, 2007).
With application of the four PMTCT ‘pillars’ (primary prevention, pre-
vention of unintended pregnancies among HIV-infected women,
PMTCT and providing care, treatment and support to HIV-positive
women and their children), it is hoped that the public health goal of
virtual elimination of HIV infection in infants (reducing MTCT to
,2%) in Europe by 2010 is within reach (Ostergren and Malyuta,
2006; Matic et al., 2008). Substantial progress has been made in redu-
cing MTCT rates in Ukraine (Thorne et al., 2009). However, little is
known about rates of unintended pregnancy and choice of contracep-
tion among HIV-infected women in Ukraine. Some Western European
studies have indicated that around half (51–58%) of pregnancies among
HIV-infected women are unintended (Fiore et al., 2006; Floridia et al.,
2007), whereas in one Russian survey of HIV-positive women, 54% of
those who had recently completed their pregnancy reported not
having planned their pregnancy (Vartapetova et al., 2006).
Unintended pregnancy among HIV-infected women in Ukraine may
elevate risk of both MTCT and infant abandonment, particularly by
marginalized women (e.g. injection drug users, illegal migrants)
(Rutenberg and Baek, 2005). Condom use within partnerships includ-
ing HIV-infected women is important regardless of the infection status
of their partners due to risk of onward transmission to HIV-negative
partners and the risk of super-infection (Gottlieb et al., 2004;
Campbell et al., 2009) within HIV concordant partnerships.
Condom use also prevents infection with other sexually transmitted
infections (STIs), some of which may hasten HIV disease progression
and increase MTCT risk (Mwapasa et al., 2006; Corey, 2007; Cowan
et al., 2008; Sheth et al., 2008; Thorne et al., 2008).
The Ukraine National Reproductive Health program states that free
contraception should be provided to all HIV-infected women, consist-
ent with UNFPA and WHO guidelines (UNFPA and World Health
Organization, 2006). Little information is currently available regarding
FP and condom use in HIV-infected women in Ukraine or elsewhere in
Eastern Europe. Our objectives were to describe the reproductive
health, condom use and FP practices of HIV-positive childbearing
Ukrainian women and to identify factors associated with condom
use in pregnancy and different methods of post-natal contraception,
within the context of this current policy.
Methods
The Ukrainian Post-natal Cohort Study of HIV-infected Childbearing
Women was established in December 2007 to follow-up the HIV
disease progression and socio-demographic characteristics of HIV-infected
childbearing women in Ukraine. The study is a nested sub-study of the
European Collaborative Study (ECS) in Ukraine that have been enrolling
mother-child pairs since 2000. The ECS is a birth cohort study addressing
MTCT and its prevention and HIV infection in pregnancy and childhood,
involving enrolment of pregnant HIV-infected women, with longitudinal
follow-up of their infants (European Collaborative Study, 2006; Thorne
et al., 2009).
Four regional HIV/AIDS centres in Ukraine participate in the post-natal
women’s cohort study: odessa, Kiev, Krivoy Rog and Donetsk. Eligibility
criteria for enrolment were HIV-positive status (diagnosed before or
during recent pregnancy or through intrapartum testing) and recent deliv-
ery. The protocol involves collection of baseline data (usually 3–6 months
post-partum), through two standardized questionnaires, one completed
by the woman and the other by her physician. Follow-up clinical infor-
mation is being collected bi-annually, but is not addressed in this paper.
All data were anonymously coded. Self-reported variables on demographic
and lifestyle factors (including age, marital status and education), health
behaviours (including condom and other contraception use, affordability
of contraception, current smoking, illicit drug use) and HIV-speciﬁc factors
(disclosure of HIV status to partner, partner’s HIV status) were collected
in the women’s questionnaire. The clinical forms collected data on hepatitis
C coinfection and STIs diagnosed during the most recent pregnancy or post-
natally, markers of HIV disease progression and antiretroviral treatment.
The majority (83%) of women had been enrolled and followed in the
ECS while pregnant, allowing linkage to ECS pregnancy data.
Deﬁnitions
Consistent condom use in pregnancy was deﬁned as condom use reported
‘most’ or ‘all of the time’ versus ‘never’ or ‘some of the time’. Effective
contraceptive methods for the purposes of our analyses were deﬁned as
the oral contraceptive pill (OCP), injectable hormone and intrauterine
device (IUD). Women reporting no use of the following were considered
to be using no post-natal contraception: condoms, coitus interruptus, OCP,
IUD, or injectable hormones.
Statistical analysis
Univariable comparisons were assessed with the x
2 test for categorical
variables. Logistic regression models were ﬁtted to obtain odds ratios
(OR) and 95% conﬁdence intervals (95% CI) and were used to identify
factors associated with consistent condom use in pregnancy and contra-
ception use post-natally. Candidate explanatory variables not associated
with outcome variables in univariable models (P . 0.10) were not con-
sidered in further analyses. Some explanatory variables were classiﬁed
into categories as follows: age (classiﬁed as ≤24, 25–29 or ≥30 years),
education (left school ≤18 or .18 years of age), bacterial STI (positive
test for Chlamydia, gonorrhoea or syphilis versus negative tests), HIV-
positive partner (no, yes, do not know/no current partner), timing of
HIV diagnosis (before this pregnancy versus during pregnancy or intrapar-
tum). The logistic models of factors associated with post-natal use of con-
traception were limited to married or cohabiting women; only 10 single,
divorced or widowed women reported being sexually active at the time
of enrolment.
Data were managed in an Access 2002 database (Microsoft Corps,
Redmond, WA, USA) and statistical analyses were performed with SAS
(v8.02, SAS Institute, USA).
Results
Cohort characteristics
By March 2009, a total of 371 women had been enrolled, at a median
of 4 months post-partum (IQR ¼ 2–15). Nearly, all were white and
born in Ukraine (327 of 330, 99%). Approximately one quarter of
women had a history of IDU or had a previous or current partner
who was an IDU; further demographic and health information is
shown in Table I. Most women had only ever had mild symptoms
of HIV disease (WHO clinical stage 1); most had CD4 counts
.350 cells/mm
3 and thus few women were currently on highly
active antiretroviral therapy (HAART) (Table I). Around one in four
women had at least one coinfection, the most common being Hepa-
titis C virus (HCV) and Herpes simplex virus-2 (HSV-2) (Table I). Just
over a quarter of women had an HIV-negative sexual partner at the
time of enrolment (27%, 97 of 363), 40% (n ¼ 145) had an
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know their partner’s status or had no current partner. Forty percent
of married or cohabiting women who knew their partners’ HIV status
were in an HIV-discordant partnership (i.e. had a negative partner) (94
of 232). The pregnancy history of participants in terms of previous
live/stillbirths, terminations and miscarriages prior to their most
recent pregnancy is illustrated in Fig. 1. Nearly a third of women
had a history of pregnancy termination, although 38% had never
been pregnant before. Most (77%, 282 of 365) women had planned
their most recent pregnancy.
Condom use in most recent pregnancy
Condom use in pregnancy was investigated according to timing of
maternal HIV diagnosis. Among 138 women known to be aware of
their HIV status before pregnancy or diagnosed in the ﬁrst trimester
of pregnancy, 22% (n ¼ 31) never used condoms in pregnancy and
35% (n ¼ 48) used condoms consistently; 55% (16 of 29) of women
with HIV-negative partners used condoms consistently compared
with 34% (19 of 56) of those with HIV-positive partners and 26%
(13 of 50) of those with partners of unknown status (x
2 ¼ 6.9, P ¼
0.03). Women with HIV-negative partners were 3.5 times more
likely to use condoms consistently than women with partners of
unknown HIV status (OR 3.50 95% CI 1.33–9.21, P ¼ 0.011) and
2.4 times more likely to do so than women with HIV-positive partners,
with borderline signiﬁcance (OR 2.40 95% CI 0.96–6.00, P ¼ 0.062).
Among women diagnosed with HIV after the ﬁrst trimester of preg-
nancy, 18% (31 of 173) never used condoms during pregnancy, with
identical proportions found in women diagnosed in the second trime-
ster (18%, 24 of135) and third trimester/intrapartum (18% 7 of 38).
The HIV status of the woman’s partner was not associated with
never/ever use of condoms in pregnancy among women diagnosed
after the ﬁrst trimester (P ¼ 0.08).
Post-natal family planning
Most (77%, 277 of 360) women reported being sexually active at the
time of enrolment. Sexual activity was signiﬁcantly associated with
marital status, with 90% (267 of 297) of married/cohabiting women
sexually active versus 16% (10 of 63) of other women (x
2¼ 160.1,
P , 0.001), and with reported affordability of contraception, with
43% (32 of 74) of women reporting that they could not afford contra-
ception being sexually active versus 85% (246 of 289) of women who
could afford it (x
2 ¼ 57.6, P , 0.001). Overall, 90% (328 of 365)
women reported having received post-natal FP counselling, of whom
the vast majority were counselled by a doctor (318 of 331, 96%) in
the HIV/AIDS centre (236 of 330, 72%). Current post-natal FP
methods reported at enrolment are presented in Fig. 2 for all
women. Although over 20% of women overall reported no current
contraception use, 80% of these (60 of 75) reported not being sexually
active currently. Of the women reporting not being sexually active at
enrolment, 45% (37 of 83) had not planned their most recent preg-
nancy, signiﬁcantly more than in the sexually active group (16%, 45
of 277) (x
2 ¼ 29.1, P , 0.01).
Condoms were the most common form of contraception, used by
half of the women. A minority of women (,4%) reported using the
OCP and condoms, although it is unclear whether this reﬂected con-
current or alternate use. We carried out logistic regression analyses to
identify predictors of post-natal condom use among sexually active,
married or cohabiting women. As women reporting condom use
and coitus interruptus or condoms and OCPs could be in either the
barrier or the non-barrier categories, two models were performed:
the ﬁrst included women reporting condom use alone or together
with another contraceptive method in the barrier group and the
second, stricter model included them in the non-barrier group. In uni-
variable models, the following were not associated with using
condoms post-natally (P . 0.10): IDU history, age, education,
history of pregnancy termination and bacterial STI; women who had
disclosed their HIV status to their partner, those who planned their
most recent pregnancy, those who had consistently used condoms
in their most recent pregnancy, those receiving post-natal FP counsel-
ling, those with HSV-2 and those currently sexually active were signiﬁ-
cantly more likely to use barrier contraception, whereas women with
an HIV-positive partner were signiﬁcantly less likely to use condoms
........................................................................................
Table I Demographic and health characteristics of the
study population.
Characteristic Nn (%) or median
(range)
Socio-demographic
Age (years) 368 27 (16-42)
Age left education (years) 196 20 (14-27)
Marital status 368
Cohabiting 90 (24.5)
Divorced 16 (4.3)
Married 213 (57.9)
Single 46 (12.5)
Widowed 3 (0.8)
Coinfections
Herpes simplex virus-2 293 75 (25.6)
Chlamydia 307 42 (13.7)
Syphilis 318 6 (1.9)
Human papilloma virus 109
Low-grade lesions 8 (7.3)
High-grade lesions 8 (7.3)
Hepatitis-C seropositive 286 81 (28.3)
HIV-related
History of injection drug use (IDU) 303 84 (27.7)
Current/former sexual partner an IDU 301 71 (23.6)
Timing of HIV diagnosis 331
Pre-pregnancy 102 (30.8)
Antenatal/intrapartum 229 (69.2)
CD4 count (mm
3) 311 435 (2–1267)
WHO clinical stage 355
I 270 (76.1)
II 14 (3.9)
III 62 (17.5)
IV 9 (2.5)
Currently receiving HAART 371 52 (14.0)
2368 Saxton et al.post-natally (Table II). In the adjusted models of post-natal condom
use, the strongest factors associated with condom use were current
sexual activity and region (Table II); consistent use of condoms in
the most recent pregnancy was associated with a 2-fold increased like-
lihood of post-natal condom use, while women with HIV-positive
partners were signiﬁcantly less likely to use condoms than women
with HIV-negative partners (Table II).
Use of effective post-natal contraception was low (Fig. 2). The only
factors predictive of use of these methods in univariable analysis were
marital status, with 21% (14/67) single, divorced or widowed women
Figure 2 Post-natal family planning methods (n ¼ 349).
Figure 1 Previous reproductive history prior to most recent pregnancy (n ¼ 331).
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married or cohabiting women (x
2 ¼ 4.9, P ¼ 0.03) and study site. In
logistic regression analysis including both variables, women living in
Kiev had a 5-fold increased likelihood of being on effective contracep-
tion compared with other women (AOR 4.88 95% CI 2.49–9.57,
P ,0.001), while married or cohabiting women were 69% less likely
to be using an effective contraceptive method (AOR 0.31 95% CI
0.15–0.66, P ¼ 0.003). Finally, we investigated factors associated
with no post-natal use of contraception among married or cohabiting,
sexually active women (Table III). In adjusted analysis, affordability of
FP and condom use in the most recent pregnancy were signiﬁcantly
associated with contraceptive use, with receipt of post-natal FP coun-
selling achieving borderline statistical signiﬁcance.
Discussion
We have described post-natal FP practices among HIV-positive child-
bearing women in Ukraine. These women were predominantly young,
married or cohabiting and at early stages of HIV disease. Around three
quarters of women had planned their most recent pregnancy and
two-thirds had not been aware of their HIV status before the preg-
nancy. Nearly half of women were using ineffective post-natal contra-
ception, and one in ﬁve was using no contraception at all, although a
relatively high proportion of this latter group reported not being cur-
rently sexually active.
The predominance of condom use for post-partum contraception
in our study population likely reﬂects the dual protection that
condoms provide against pregnancy and acquisition or transmission
of HIV and other STIs. This is underscored by the 2–3-fold increased
likelihood of condom use post-partum in women who used condoms
during pregnancy and in those who had HIV-negative partners. The
ﬁnding that more women in HIV-discordant couples used condoms
.................................................... ................................
...............................................................................................................................................................................................
Table II Use of post-natal barrier contraception and associated factors.
Unadjusted rate of
barrier
contraception (%)
Model 1 any condom use (n 5 207) Unadjusted rate
of strict barrier
contraception (%)
Model 2 only condom
use (n 5 192)
OR P AOR (95% CI) P AOR (95%
CI)
P
Partner HIV positive
No 80/95 (84.2) 1.00 1.00 63/95 (66.3) 1.00
Do not know/no partner 50/110 (45.5) 0.37 0.03 0.57 (0.19–1.68) 0.30 37/110 (33.6) 0.61 (0.26–1.46) 0.27
Yes 102/142 (71.8) 0.48 0.07 0.35 (0.13–0.95) 0.04 72/142 (50.7) 0.46 (0.22–0.98) 0.044
Study site
Odessa, Donetsk, Krivoy Rog 152/262 (58.0) 1.00 1.00 107/262 (40.8) 1.00
Kiev 82/87 (94.3) 8.50 0.0006 6.89 (1.86–25.5) 0.004 67/87 (77.0) 3.35 (1.53–7.32) 0.003
Timing of HIV diagnosis
Prior to this pregnancy 53/89 (59.6) 1.00 1.00 38/89 (42.7) 1.00
During pregnancy/at delivery 143/202 (70.8) 0.48 0.049 0.72 (0.32–1.61) 0.42 109/202 (54.0) 0.81 (0.41–1.60) 0.54
Condom use in most recent pregnancy
Inconsistent use 106/187 (54.1) 1.00 1.00 74/187 (39.6) 1.00
Consistent use 127/159 (79.9) 3.02 0.003 2.39 (1.06–5.40) 0.035 99/159 (62.3) 1.88 (1.01–3.50) 0.045
Post-natal family planning counselling
Not received 14/34 (41.2) 1.00 1.00 12/34 (35.3) 1.00
Received 220/315 (69.8) 2.95 0.078 2.68 (0.69–10.4) 0.15 162/315 (51.4) 1.05 (0.30–3.61) 0.94
HSV-2 coinfection
No 127/208 (61.1) 1.00 1.00 88/208 (42.3) 1.00
Yes 56/71 (78.9) 2.31 0.063 1.34 (0.47–3.78) 0.58 41/71 (57.8) 0.86 (0.39–1.88) 0.86
........................................................................................
Table III Factors associated with no post-natal
contraceptive use among married and cohabiting,
sexually active women (n 5 216).
OR P AOR (95% CI) P
Affordability of contraception
Affordable 1.00 1.00
Not affordable 10.1 ,0.001 6.34 (1.73–23.2) 0.005
Study site
Odessa, Donetsk,
Krivoy Rog
1.00 1.00
Kiev 0.16 0.08 0.17 (0.02–1.56) 0.12
Condom use during most recent pregnancy
Consistent use 1.00 1.00
Inconsistent use 8.09 0.007 7.25 (1.41–37.2) 0.02
Post-natal family planning counselling
Received 1.00 1.00
Not received 4.99 0.013 3.99 (0.91–17.6) 0.06
2370 Saxton et al.than those in concordant couples is consistent with other studies
(Heard et al., 2004). However, one in six married/cohabiting
women in discordant partnerships were not using barrier methods
at all. Several studies have reported that, in HIV discordant partner-
ships where the woman is infected, risk of onward transmission is
sometimes perceived as negligible (Stevens and Galvao, 2007;
Sanders, 2009) and, in one study, intercourse without barrier contra-
ception was more common when the female rather than the male was
infected (Bouhnik et al., 2007). Transmission risk per sex act for
female-to-male HIV transmission is estimated to range from 0.04%
in high income settings to 0.38% in low income settings in the
absence of antiretroviral therapy; furthermore, genital ulcers in
either partner is estimated to increase infectivity 5-fold (Boily et al.,
2009). A quarter of women in our study had been recently diagnosed
with at least one STI, and only 14% were on HAART, indicating the
potential for onward transmission to HIV-negative partners. Previous
research has indicated that many concordant couples do not perceive
any advantage to using condoms (Heard et al., 2004; Stanwood et al.,
2007), however in this study more than 50% of discordant couples
used condoms.
In our study, 40% of women were using ineffective, unreliable post-
natal contraception methods or nothing at all and risk future
unplanned pregnancy. Although many women reporting no current
use of FP methods were not sexually active, it is likely that many
will resume sexual activity, raising questions on preparedness to use
FP. Our ﬁnding that signiﬁcantly more women who, at enrolment,
were sexually inactive than active had not planned their most recent
pregnancy suggests that they may be at increased risk of future unin-
tended pregnancy. Time to resumption of sexual activity after child-
birth is estimated to be 6–8 weeks in the general population in
Europe (Vikhlyaeva et al., 2001; van Brummen et al., 2006; Radestad
et al., 2008). In our study, 77% of women reported having resumed
sexual activity at a median of 2 months post-partum. The likelihood
of future unintended pregnancies in our study population is under-
scored by their reproductive histories, with a third having previous
pregnancy terminations.
The reproductive and FP behaviours reported here need interpret-
ation within the national context. FP provision and uptake have been
low historically in the former Soviet Union, with high prevalence of tra-
ditional methods, and this has largely continued to date (Popov et al.,
1993; Perlman and McKee, 2009). However, a study in the Russian
Federation indicated an increased use of barrier contraception, from
9% in 1994 to 21% in 2003, possibly reﬂecting HIV awareness
(Perlman and McKee, 2009). In studies in Ukraine, 51% of nearly
300 sexually active, non-pregnant women had not used contraception
in the previous month (Mogilevkina and Odlind, 2003) and 20% of
medical students had not used contraception at their most recent
coitus (Mogilevkina et al., 2001).
In the Ukraine, among the general population, costs of contracep-
tion are not met by the health system. In our study, the lack of post-
natal contraception was strongly associated with affordability, despite
the ofﬁcial policy of free provision of contraception to HIV-positive
women, indicating that this policy is not effectively implemented.
The strong association found between current sexual activity and
affordability of contraception is noteworthy and requires further inves-
tigation. Our ﬁnding that women in Kiev were three times more likely
to use condoms post-natally than women attending other sites reﬂects
more active promotion and greater availability of condoms in Kiev than
in other sites; in Kiev, free condoms are available in a variety of places
within the AIDS Centre, including the waiting room. There was good
coverage of post-natal FP counselling among our study population,
with only 10% of women not receiving counselling. Our results high-
light the importance of such counselling, as women not receiving it
were four times more likely not to be using any contraceptive
method than women who did.
Contraceptive use is generally inﬂuenced by a large number of
factors, including access to FP, social norms about contraception,
acceptability of different methods to both the woman and her
partner and desire for a pregnancy. FP decisions for couples where
one or both partners are HIV-positive are complicated by risk of
sexual transmission of HIV. Counselling on safe sex and FP should con-
sider the couple and their life choices and a pragmatic approach may
be the most effective. For example, in an HIV-concordant couple, if
long-term condom use is unlikely, counselling could focus on the
beneﬁts of using condoms in subsequent pregnancies or encouraging
STI testing and treatment of both partners. There is conﬂicting evi-
dence regarding the impact of hormonal contraception on HIV
disease progression (Stringer et al., 2007; Stringer et al., 2009a, b),
although IUDs appear to be a safe and effective FP method for
HIV-infected women (Stringer et al., 2007); both methods were
rarely used in our population.
The Glion Call to Action called for strengthening linkages between
PMTCT and FP services (UNFPA and WHO, 2006), but prevention of
unintended pregnancy has received substantially less attention than
other components (Rutenberg and Baek, 2005; Delvaux and
Nostlinger, 2007). In Ukraine, the main focus of the national
PMTCT programme has been on antenatal HIV testing and provision
of PMTCT interventions. The broader beneﬁts of reducing unintended
pregnancies in HIV-infected women extend beyond the prevention of
new HIV infections in infants: women with access to FP services are
able to decide on the number and spacing of their children, to avoid
induced abortion (safe and unsafe) and reduce their own chances of
acquiring STIs as well as limiting their potential for onward trans-
mission to sexual partners.
There are several limitations to this observational study, which has
potential for both measured and unmeasured confounding. Most data
were collected in the post-natal period that may not reﬂect longer-
term post-natal FP and sexual activity. Although we collected infor-
mation on condom use in pregnancy, we had no data on sexual activity
in pregnancy. The analyses presented use baseline data collected at
enrolment and are thus cross-sectional; we are therefore unable to
comment on whether signiﬁcant variables identiﬁed in this observa-
tional study were causally related to FP outcomes and whether they
remain signiﬁcant over time. However, as this is an ongoing cohort,
longitudinal examination of these relationships in the future will be
possible, including estimates of incidence of planned and unplanned
sequential pregnancies. Use of self-administered questionnaires pre-
vented interviewer-related bias, but there may still have been potential
for social desirability bias introduced by this methodology. Our study
population is representative of HIV-infected childbearing women in
Ukraine participating in a larger epidemiological study (Thorne et al.,
2009); however, caution should be taken in generalizing these
results to populations of HIV-positive childbearing women in other
settings. All the women in our cohort had completed their pregnancies
Contraceptive use among HIV-infected women in Ukraine 2371and thus our results may not apply to the HIV-positive pregnant popu-
lation as a whole. In particular, the proportion of women whose most
recent pregnancy was unplanned (23%) is likely to be lower than it
would be for the entire pregnant, HIV-infected population, which
would include women with unintended pregnancies who had preg-
nancy terminations.
Conclusion
An unacceptably high proportion of our population of post-natal HIV-
positive women was using ineffective or unreliable FP methods, or
none, and thus will be at risk of future unintended pregnancy. Use
of oral contraceptives, injectable contraceptives and IUDs was low.
Although condoms were more likely to be used by those needing
to use them most (i.e. discordant couples), our results indicate poten-
tial for onward heterosexual transmission to uninfected sexual part-
ners in this population. Access to FP is an unmet need of many
HIV-positive post-natal women in Ukraine, with lack of affordability
a key barrier. Programme efforts should focus on implementing free
provision of contraception and enhancing access to post-natal FP
counselling.
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